SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Caplin Point gets EU GMP approval for Sterile Injectable Site

09 Jul 2015 Evaluate

Caplin Point Laboratories has received EU GMP approval for its small volume sterile injectable liquids facility at Chennai. The site was inspected by the EU authorities in March 2015 and has been certified as compliant with the guidelines. The facility is capable of manufacturing Liquid Injectables in Vials, Ampoules, Lyophilized Vials and Opthalmic dosages.

EU approval grants access not only to the European Union, but also several other countries in the Regulated domain through mutual recognition process.

Caplin Point Laboratories is a niche pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa.


Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×